The company’s Phase I trial found that patients remained disease free after three months utilising the lowest doses of RAG-01 ...

A healthy 60-year-old man presented with a recurrent lesion on his left third finger after surgical treatment 7 years previously (Figure 1). A biopsy reveals squamous cell carcinoma (SCC) in situ.

What Is Invasive Lobular Carcinoma? Invasive lobular carcinoma (ILC) is a type of breast cancer. It begins in lobules — the cells of the mammary glands that make milk — and spreads to other ...

Carcinoma is a type of cancer that starts in cells that make up the skin or the tissue lining organs, such as the liver or kidneys. Like other types of cancer, carcinomas are abnormal cells that ...

Ductal carcinoma in situ (DCIS) is an early form of cancer confined to the lactiferous (milk producing) ducts of the breast. The choice of whether surgery is required or what surgery is best for you ...

Cretostimogene treatment shows best-in-class durability of response for BCG-unresponsive non-muscle invasive bladder cancer ...

CG Oncology (CGON) announced that 83 out of 110 patients achieved a complete response at any time in a Phase 3 study of cretostimogene ...

Havah Therapeutics, a clinical stage biopharmaceutical company developing innovative therapies for prevention and treatment of breast cancers, announces the filing of a new provisional patent ...

Cretostimogene Monotherapy Demonstrated Sustained, Durable Complete Responses in High-Risk Bacillus Calmette Guérin (BCG)-Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC) - - Initiated CORE-008 ...